Tyrosinemia, Type III
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
We report the case of a boy with tyrosinemia Type III detected using neonatal screening, who is homozygous for the splice donor mutation IVS11+1G>A in intron 11 of the HPD gene.
|
23036342 |
2012 |
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
CLINGEN |
We report the case of a boy with tyrosinemia Type III detected using neonatal screening, who is homozygous for the splice donor mutation IVS11+1G>A in intron 11 of the HPD gene.
|
23036342 |
2012 |
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III.
|
17560158 |
2007 |
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
BEFREE |
Congenital HPD deficiency is a rare, relatively benign condition known as hereditary type III tyrosinemia.
|
12127941 |
2002 |
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
CLINGEN |
A homozygous missense mutation predicting an Ala to Val change at codon 268 (A268V) in the HPD gene was found in the patient with tyrosinemia type III.
|
11073718 |
2000 |
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
CLINGEN |
We have identified four presumed pathogenic mutations (two missense and two nonsense mutations) in the HPD gene in three unrelated families encompassing four homozygous individuals and one compound heterozygous individual with tyrosinemia type III.
|
10942115 |
2000 |
Tyrosinemia, Type III
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
A homozygous missense mutation predicting an Ala to Val change at codon 268 (A268V) in the HPD gene was found in the patient with tyrosinemia type III.
|
11073718 |
2000 |
Tyrosinemia, Type III
|
0.940 |
GeneticVariation
|
disease |
UNIPROT |
A homozygous missense mutation predicting an Ala to Val change at codon 268 (A268V) in the HPD gene was found in the patient with tyrosinemia type III.
|
11073718 |
2000 |
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We have identified four presumed pathogenic mutations (two missense and two nonsense mutations) in the HPD gene in three unrelated families encompassing four homozygous individuals and one compound heterozygous individual with tyrosinemia type III.
|
10942115 |
2000 |
Tyrosinemia, Type III
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
We have identified four presumed pathogenic mutations (two missense and two nonsense mutations) in the HPD gene in three unrelated families encompassing four homozygous individuals and one compound heterozygous individual with tyrosinemia type III.
|
10942115 |
2000 |
Tyrosinemia, Type III
|
0.940 |
GeneticVariation
|
disease |
UNIPROT |
We have identified four presumed pathogenic mutations (two missense and two nonsense mutations) in the HPD gene in three unrelated families encompassing four homozygous individuals and one compound heterozygous individual with tyrosinemia type III.
|
10942115 |
2000 |
Tyrosinemia, Type III
|
0.940 |
GermlineCausalMutation
|
disease |
ORPHANET |
We have identified four presumed pathogenic mutations (two missense and two nonsense mutations) in the HPD gene in three unrelated families encompassing four homozygous individuals and one compound heterozygous individual with tyrosinemia type III.
|
10942115 |
2000 |
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
CLINGEN |
In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice.
|
8989996 |
1997 |
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
CLINGEN |
A nonsense mutation in the 4-hydroxyphenylpyruvic acid dioxygenase gene (Hpd) causes skipping of the constitutive exon and hypertyrosinemia in mouse strain III.
|
7774914 |
1995 |
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
MGD |
A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.
|
2014797 |
1991 |
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
CLINGEN |
Assay, properties and tissue distribution of p-hydroxyphenylpyruvate hydroxylase.
|
4627454 |
1972 |
Tyrosinemia, Type III
|
0.940 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Tyrosinemia, Type III
|
0.940 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hawkinsinuria
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Two mutations of HPD gene, A33T, which are associated with hawkinsinuria and a novel one (V212M) were detected for the 1st time in Greek newborns.
|
26226126 |
2016 |
Hawkinsinuria
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria.
|
20677779 |
2010 |
Hawkinsinuria
|
0.730 |
GeneticVariation
|
disease |
ORPHANET |
Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III.
|
17560158 |
2007 |
Hawkinsinuria
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III.
|
17560158 |
2007 |
Hawkinsinuria
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.
|
10942115 |
2000 |
Hawkinsinuria
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
A heterozygous missense mutation predicting an Ala to Thr change at codon 33 (A33T) was found in the same HPD gene in the two patients with hawkinsinuria.
|
11073718 |
2000 |
Hawkinsinuria
|
0.730 |
GeneticVariation
|
disease |
ORPHANET |
A heterozygous missense mutation predicting an Ala to Thr change at codon 33 (A33T) was found in the same HPD gene in the two patients with hawkinsinuria.
|
11073718 |
2000 |